These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8748085)

  • 21. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.
    Martin R; McFarland HF
    Crit Rev Clin Lab Sci; 1995; 32(2):121-82. PubMed ID: 7598789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental allergic encephalomyelitis as an animal model for multiple sclerosis].
    Lukinović-Skudar V; Taradi SK; Andreis I; Zupancić V; Taradi M
    Lijec Vjesn; 2001; 123(3-4):81-8. PubMed ID: 11488222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hormonal disturbances in patients with multiple sclerosis].
    Ziaber J; Chmielewski H
    Neurol Neurochir Pol; 1993; 27(4):575-82. PubMed ID: 8247245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple Sclerosis: Basic and Clinical.
    Buzzard K; Chan WH; Kilpatrick T; Murray S
    Adv Neurobiol; 2017; 15():211-252. PubMed ID: 28674983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
    Lee DH; Linker RA
    Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
    Gonçalves ED; Souza PS; Lieberknecht V; Fidelis GS; Barbosa RI; Silveira PC; de Pinho RA; Dutra RC
    Autoimmunity; 2016; 49(2):132-42. PubMed ID: 26703077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
    Elieh-Ali-Komi D; Cao Y
    Clin Rev Allergy Immunol; 2017 Jun; 52(3):436-445. PubMed ID: 28025778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting monocyte recruitment in CNS autoimmune disease.
    Izikson L; Klein RS; Luster AD; Weiner HL
    Clin Immunol; 2002 May; 103(2):125-31. PubMed ID: 12027417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis.
    Hafler DA
    J Clin Invest; 1999 Sep; 104(5):527-9. PubMed ID: 10487765
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of cytokines in experimental autoimmune encephalomyelitis.
    Bettelli E; Nicholson LB
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):389-98. PubMed ID: 11140466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal factors in susceptibility to multiple sclerosis.
    Duquette P; Girard M
    Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):195-201. PubMed ID: 8481563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multiple sclerosis and immunity].
    Kroda Y; Kawanami S; Kuroiwa Y
    Nihon Rinsho; 1973 Dec; 31(12):3381-6. PubMed ID: 4134071
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytokine-directed therapies in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Ruuls SR; Sedgwick JD
    Immunol Cell Biol; 1998 Feb; 76(1):65-73. PubMed ID: 9553778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Signaling pathways and therapeutic perspectives related to environmental factors associated with multiple sclerosis.
    Tiwari S; Lapierre J; Ojha CR; Martins K; Parira T; Dutta RK; Caobi A; Garbinski L; Ceyhan Y; Esteban-Lopez M; El-Hage N
    J Neurosci Res; 2018 Dec; 96(12):1831-1846. PubMed ID: 30204260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis.
    Abdul-Majid KB; Stefferl A; Bourquin C; Lassmann H; Linington C; Olsson T; Kleinau S; Harris RA
    Scand J Immunol; 2002 Jan; 55(1):70-81. PubMed ID: 11841694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies.
    Racke MK
    Curr Opin Neurol; 2008 Apr; 21 Suppl 1():S9-S18. PubMed ID: 18388801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
    Humle Jorgensen S; Sorensen PS
    J Neurol Sci; 2005 Jun; 233(1-2):61-5. PubMed ID: 15949496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.
    Raine CS
    Lab Invest; 1984 Jun; 50(6):608-35. PubMed ID: 6202955
    [No Abstract]   [Full Text] [Related]  

  • 40. Protective Effects on Central Nervous System by Acidic Polysaccharide of Panax ginseng in Relapse-Remitting Experimental Autoimmune Encephalomyelitis-Induced SJL/J Mice.
    Bing SJ; Ha D; Hwang I; Park E; Ahn G; Song JY; Jee Y
    Am J Chin Med; 2016; 44(6):1099-1110. PubMed ID: 27627913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.